Commentary

Hypertriglyceridemia


 

• Patients who have very severe hypertriglyceridemia with pancreatitis should not be treated with heparin infusions or plasmapheresis. Treatment of hypertriglyceridemia in these patients should focus on treating the underlying cause, dietary fat restriction, and starting long-term fibrate therapy.

Reference

Berglund L. et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. (J. Clin. Endocrinol. Metab. 2012,97:2969-89).

Dr. Alexander is an assistant professor of internal medicine and pediatrics, and associate program director of the med-peds residency at the University of Arkansas, Little Rock. Dr. Golden is medical director of Arkansas Medicaid and professor of medicine and public health at the University of Arkansas. Dr. Hopkins is director of the division of general internal medicine at the University of Arkansas. E-mail them at imnews@elsevier.com. They reported having no relevant financial conflicts.

Pages

Recommended Reading

Polypill Improves Cardiovascular Health in UMPIRE
MDedge Internal Medicine
Early results promising for micropump in heart failure
MDedge Internal Medicine
Hypertension Underdiagnosed in Young Adults in Primary Care
MDedge Internal Medicine
Osteoporosis, Vertebral Fractures May Flag Heart Risk in RA
MDedge Internal Medicine
ICDs' Role Remains Uncertain in CKD Patients
MDedge Internal Medicine
PCSK9 Antibodies Safely Cut LDL in Phase II
MDedge Internal Medicine
Ultrafiltration Flops for Acute Cardiorenal Syndrome
MDedge Internal Medicine
Statins' Diabetogenic Impact Influenced by Underlying Risks
MDedge Internal Medicine
ICD Shocks Boost Anxiety and Mortality
MDedge Internal Medicine
LBBB Poses Biggest Intraventricular Conduction-Block Risk
MDedge Internal Medicine